BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2879069)

  • 21. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria.
    Lillie C; Kobinger W
    J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
    Hedberg A; Mattsson H; Nerme V; Carlsson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.
    Vatner DE; Lavallee M; Amano J; Finizola A; Homcy CJ; Vatner SF
    Circ Res; 1985 Jul; 57(1):55-64. PubMed ID: 2988820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions between prostaglandins E2 and F2alpha and isoprenalin in the dog heart in situ].
    Förster W; Schrör K; Weiss M
    Acta Biol Med Ger; 1975; 34(3):501-6. PubMed ID: 1189822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on bradycardia mechanism in the moderately hypothermic dog.
    Estima-Martins AM
    Rev Esp Fisiol; 1975 Dec; 31(4):277-82. PubMed ID: 1215620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β
    Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
    Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased sensitivity to isoprenaline following digoxin pretreatment in anaesthetised and conscious dogs.
    Mihailidou AS; Einstein R; Richardson DP; Gray P; Jones MP; Hunyor SN
    Cardiovasc Res; 1990 Mar; 24(3):222-6. PubMed ID: 2346956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs.
    Einstein R; Goodman AH; Yeoh EB
    J Auton Pharmacol; 1986 Mar; 6(1):9-14. PubMed ID: 3957953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
    Akahane K; Furukawa Y; Ogiwara Y; Haniuda M; Chiba S
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1276-82. PubMed ID: 2539461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog.
    Vatner SF; Hintze TH; Macho P
    Circ Res; 1982 Jul; 51(1):56-66. PubMed ID: 6282497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs.
    Vatner SF; Knight DR; Hintze TH
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H49-56. PubMed ID: 2861749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of isoproterenol-induced calorigenic action in the heart during myocardial ischemia.
    Juhász-Nagy A; Kékesi V; Papp L
    Acta Biol Hung; 1988; 39(1):31-8. PubMed ID: 2855382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
    Kenakin TP; Beek D
    J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of mechanical effects and beta-adrenoceptor binding of prenalterol in rat myocardium.
    Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):3-11. PubMed ID: 6310958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.